News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
292,347 Results
Type
Article (16563)
Company Profile (307)
Press Release (275477)
Section
Business (87249)
Career Advice (323)
Deals (14959)
Drug Delivery (34)
Drug Development (52144)
Employer Resources (37)
FDA (6459)
Job Trends (5813)
News (156828)
Policy (11112)
Tag
Academia (1137)
Alliances (23552)
Alzheimer's disease (814)
Approvals (6445)
Artificial intelligence (91)
Bankruptcy (136)
Best Places to Work (5012)
Biotechnology (252)
Breast cancer (122)
Cancer (1033)
Cardiovascular disease (85)
Career advice (278)
CAR-T (82)
Cell therapy (243)
Clinical research (41703)
Collaboration (400)
Compensation (153)
COVID-19 (1118)
C-suite (107)
Cystic fibrosis (72)
Data (1091)
Diabetes (103)
Diagnostics (1590)
Earnings (32354)
Events (50003)
Executive appointments (319)
FDA (6915)
Funding (381)
Gene editing (70)
Gene therapy (181)
GLP-1 (341)
Government (1216)
Healthcare (7443)
Infectious disease (1159)
Inflammatory bowel disease (102)
IPO (7886)
Job creations (1092)
Job search strategy (238)
Layoffs (225)
Legal (1621)
Lung cancer (147)
Lymphoma (67)
Manufacturing (97)
Medical device (3645)
Medtech (3646)
Mergers & acquisitions (7258)
Metabolic disorders (297)
Neuroscience (1104)
NextGen: Class of 2025 (2318)
Non-profit (1067)
Northern California (1257)
Obesity (161)
Opinion (109)
Parkinson's disease (84)
Patents (77)
People (27206)
Phase I (14586)
Phase II (19289)
Phase III (12393)
Pipeline (460)
Postmarket research (926)
Preclinical (6222)
Radiopharmaceuticals (210)
Rare diseases (227)
Real estate (1676)
Regulatory (9096)
Research institute (1092)
Series A (75)
Southern California (1122)
Startups (2115)
United States (10035)
Vaccines (192)
Weight loss (96)
Date
Today (77)
Last 7 days (235)
Last 30 days (1242)
Last 365 days (21686)
2025 (1096)
2024 (21879)
2023 (23901)
2022 (29544)
2021 (30066)
2020 (25765)
2019 (18455)
2018 (13485)
2017 (15360)
2016 (13432)
2015 (16200)
2014 (11638)
2013 (8638)
2012 (8684)
2011 (8862)
2010 (8481)
Location
Africa (183)
Asia (18472)
Australia (3129)
California (2859)
Canada (946)
China (251)
Colorado (108)
Connecticut (130)
Europe (41044)
Florida (343)
Georgia (86)
Illinois (184)
Indiana (75)
Japan (68)
Maryland (382)
Massachusetts (2245)
Minnesota (136)
New Jersey (719)
New York (783)
North Carolina (465)
Northern California (1257)
Ohio (95)
Pennsylvania (560)
South America (268)
Southern California (1122)
Texas (323)
Washington State (271)
292,347 Results for "structure therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
November 15, 2024
·
1 min read
Press Releases
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
October 31, 2024
·
1 min read
Press Releases
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
November 14, 2024
·
10 min read
Press Releases
Peptone Announces Key Leadership Appointments to Progress Novel Protein Structural Insights for Intrinsically Disordered Protein-Driven Therapeutics
January 10, 2025
·
5 min read
Biotech Bay
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced the pricing of its upsized underwritten public offering of 9,066,972 American depositary shares (ADSs), each representing three ordinary shares, at a public offering price of $52.50 per ADS.
June 5, 2024
·
4 min read
Press Releases
Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
December 18, 2024
·
7 min read
Business
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, reported financial results for the first quarter ended March 31, 2024, and highlighted recent corporate achievements.
May 9, 2024
·
8 min read
Business
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
August 27, 2024
·
5 min read
Business
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
August 26, 2024
·
1 min read
Biotech Bay
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants - June 03, 2024
Structure Therapeutics Inc. announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed underwritten public offering of 8,000,000 American depositary shares, each representing three ordinary shares.
June 3, 2024
·
5 min read
1 of 29,235
Next
